BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29441914)

  • 1. Effects of taurochenodeoxycholic acid on Ca
    Lei Z; Xudong W; Wei M
    Pharmazie; 2016 Jul; 71(7):390-393. PubMed ID: 29441914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurochenodeoxycholic acid mediates cAMP-PKA-CREB signaling pathway.
    Qi YC; Duan GZ; Mao W; Liu Q; Zhang YL; Li PF
    Chin J Nat Med; 2020 Dec; 18(12):898-906. PubMed ID: 33357720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5.
    Qi Y; Shi L; Duan G; Ma Y; Li P
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurochenodeoxycholic acid reduces astrocytic neuroinflammation and alleviates experimental autoimmune encephalomyelitis in mice.
    Xu N; Bai Y; Han X; Yuan J; Wang L; He Y; Yang L; Wu H; Shi H; Wu X
    Immunobiology; 2023 May; 228(3):152388. PubMed ID: 37079985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC/JNK-dependent pathway.
    Wang X; Zhang Z; He X; Mao W; Zhou L; Li P
    Eur J Pharmacol; 2016 Sep; 786():109-115. PubMed ID: 27268718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome investigation of anti-inflammation and immuno-regulation mechanism of taurochenodeoxycholic acid.
    Bao L; Hao D; Wang X; He X; Mao W; Li P
    BMC Pharmacol Toxicol; 2021 Apr; 22(1):23. PubMed ID: 33926569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice.
    Zhou C; Shi Y; Li J; Zhang W; Wang Y; Liu Y; Liu J
    Pak J Pharm Sci; 2013 Jul; 26(4):761-5. PubMed ID: 23811455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells.
    Yanguas-Casás N; Barreda-Manso MA; Nieto-Sampedro M; Romero-Ramírez L
    J Cell Physiol; 2017 Aug; 232(8):2231-2245. PubMed ID: 27987324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurochenodeoxycholic Acid Inhibited AP-1 Activation via Stimulating Glucocorticoid Receptor.
    Li L; Liu C; Mao W; Tumen B; Li P
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes.
    Hirano F; Haneda M; Makino I
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1807-13. PubMed ID: 17074018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP/PKA pathway in pancreatic beta cells.
    Vettorazzi JF; Ribeiro RA; Borck PC; Branco RC; Soriano S; Merino B; Boschero AC; Nadal A; Quesada I; Carneiro EM
    Metabolism; 2016 Mar; 65(3):54-63. PubMed ID: 26892516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers.
    Rust C; Bauchmuller K; Fickert P; Fuchsbichler A; Beuers U
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G88-94. PubMed ID: 15746212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurochenodeoxycholic acid induces apoptosis of fibroblast-like synoviocytes.
    Li L; Liu C; Liu M; Shi L; Liu Q; Guan H; Li P
    Eur J Pharmacol; 2013 Apr; 706(1-3):36-40. PubMed ID: 23510744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma.
    Song WS; Park HM; Ha JM; Shin SG; Park HG; Kim J; Zhang T; Ahn DH; Kim SM; Yang YH; Jeong JH; Theberge AB; Kim BG; Lee JK; Kim YG
    Sci Rep; 2018 Jul; 8(1):11088. PubMed ID: 30038332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes.
    Beuers U; Nathanson MH; Boyer JL
    Gastroenterology; 1993 Feb; 104(2):604-12. PubMed ID: 8425704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells.
    Kida T; Tsubosaka Y; Hori M; Ozaki H; Murata T
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1663-9. PubMed ID: 23619297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells.
    Kowal JM; Haanes KA; Christensen NM; Novak I
    Cell Commun Signal; 2015 Jun; 13():28. PubMed ID: 26050734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids induce eosinophil degranulation by two different mechanisms.
    Yamazaki K; Gleich GJ; Kita H
    Hepatology; 2001 Mar; 33(3):582-90. PubMed ID: 11230738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of 17 beta-estradiol on intracellular free calcium, inositol-1,4,5-trisphophate and calmodulin in human osteoblast-like osteosarcoma cell line TE85].
    Liu J; Sun L; Wang Q; Zheng H; Wong L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Apr; 21(2):105-10. PubMed ID: 12569664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurochenodeoxycholic acid inhibits intestinal epithelial cell proliferation and induces apoptosis independent of the farnesoid X receptor.
    Liu Y; Niu K; Wang R; Liang X; Lin C; Wu X; Zhai Z
    Food Funct; 2023 Jun; 14(11):5277-5289. PubMed ID: 37195071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.